Cardiac and vascular abnormalities in renal transplant patients: Differential effects of cyclosporin and azathioprine

Journal of Nephrology

Volumn 13, Issue 3, 2000, Pages 185-192

  Galiatsou, Eftychia ^a   Morris, Scott T W ^a   Jardine, Alan G ^a   Rodger, R Stuart C ^a   Watson, Mary A ^a   Elliott, Henry L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Blood pressure control; Cardiovascular abnormalities; Immunosuppressant drugs; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN;

ARTERY CALCIFICATION; ARTERY WALL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AZATHIOPRINE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; CYCLOSPORINE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RENAL REPLACEMENT THERAPY; TIME FACTORS;

EID: 0033922382     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Parfrey PS. Cardiac disease in chronic uremia; pathophysiology and clinical epidemiology. ASAIO J 1994; 40: 121-9.
2. Raine AEG, Margreiter R, Brunner FP, Ehrich JHH, Geerlings W, Landais P, Loirat C, Mallick NP, Selwood NH, Tufveson G, Valderrabano F. Report on management renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1998; 7: 7-35.
3. Kasiske BL, Guijarro C, Massy ZA, Wederkehr MR, Ma J. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-65.
4. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-90.
5. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277-85.
6. Stewart GA, Foster J, Cowan M, Rooney E, McDonagh T, Dargie HJ, Rodger RSC, Jardine AG. Echocardiography over-estimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int 1999; 56: 2248-53.
7. McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RSC, Junor BJR, McMillan MA, Briggs JD. Pre-operative echocardiographic abnormalities and outcome following renal transplantation. Nephrol Dial Transplant 1998; 13: 1499-505.
8. McGregor E, Stewart G, Rodger RSC, Jardine AG. Early echocardiographic changes and outcome following renal transplantation. Nephrol Dial Transplant 2000; 15: 93-9.
9. Silberberg JS, Rahal DP, Sniderman AD. Role of anemia in the pathogenesis of left ventricular hypertrophy in endstage renal disease. Am J Cardiol 1989; 64: 222-4.
10. Curtis JJ. Hypertension following kidney transplantation. Am J Kidney Dis 1994; 23: 471-5.
11. Levy D, Garrison RJ, Davage DD, Kannell WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framiongham heart study. N Engl J Med 1990; 332: 1561-6.
12. Amann K, Ritz E: Cardiac structure and function in renal disease. Curr Opin Nephrol Hypertens 1996; 5: 102-6.
13. Watson MA, Briggs JD, Junor BJR, McMillan MA, MacPherson SG, Murray G, Stewart RM. Randomised trial of conversion from cyclosporin to azathioprine one year after renal transplantation. Transplant Proc 1989; 21: 15834.
14. Morris STW, Galiatsou E, Stewart GA, Rodger RSC, Jardine AG. QT dispersal before and after dialysis. J Am Soc Nephrol 1999; 10: 160-3.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
16. Devereux RB. Detection of left ventricular hypertrophy by M-Mode echocardiography anatomic validation, standardization and comparison to other methods. Hypertension 1987; 9 (suppl 2): S19-26.
17. Schiller NB. Considerations in the standardization of measurement of left ventricular myocardial mass by two-dimensional echocardiography. Hypertension 1987; 9 (suppl 2): S33-5.
18. Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, Alderman MH, Devereux RB. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909-18.
19. Dubois D, Dubois EF. Clinical calorimetry: a formula to estimate the approximate surface mass if height and weight are known. Arch Intern Med 1916; 17: 863-71.
20. Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction: A noninvasive method to predict coronary atherosclerosis. Circulation 1989; 80: 78-86.
21. Nishimura RA, Housmans PR, Hatle LK, Tajik AJ. Assesmem of diastolic function of the heart: background and current applications of doppler echocardiography. Part II. Clinical Studies. Mayo Clin Proc 1989; 64: 181-204.
22. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-406.
23. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, Pessina A, Porcellati C, Salvetti A, Trimarco B. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95: 1464-70.
24. Hüting J. Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol 1992; 70: 1481-4.
25. van den Dorpel M, van den Meiracker AH, Lameris TW, Boomsma F, Levi M, Man in't Veld AJ, Weimar W, Schaleamp MADH. Cyclosporin A impairs the nocturnal blood pressure fall in renal transplant recipients. Hypertension 1996; 28: 304-7.
26. Reeves RA, Shapiro AP, Thompson ME, Johnsen AM. Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 1986; 73: 401-8.
27. Textor SC. De novo hypertension after liver transplantation. Hypertension 1993; 25: 257-67.
28. Lipkin GW, Tucker B, Giles M, Raine AEG. Ambulatory blood pressure and left ventricular mass in cyclosporin-and non-cyclosporin-treated renal transplant recipients. J Hypertens 1993; 11: 439-42.
29. van de Borne P, Gelin M, Degante J. Circadian rhythms of blood pressure after liver transplantation. Hypertension 1993; 21: 398-405.
30. Keitel L, Fuchs FD, Costa CA, Bittar JC, Goldani JC, Garcia VD. Loss of blood pressure circadian rhythm in renal transplant recipients taking cyclosporine. Transplant Proc 1997; 29: 222.
31. van de Borne P, Leeman M, Primo G, Degante J. Reappearance of a normal circadian rhythm of blood pressure after cardiac transplantation. Am J Cardiol 1992; 69: 794-801.
32. Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RSA, Ring S, Hanson P, Mohanty PK, Victor RG. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990; 323: 693-9.
33. Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 1991; 18: 1287-94.
34. Hang C, Duell T, Voisard R, Lenich A, Kolb HJ, Mickley V, Hombach V, Grünert A. Cyclosporin A stimulates endothelin release. J Cardiovas Pharmacol 1995; 26 (suppl. 3): S239-41.
35. Bartholomeusz B, Hardy KJ, Nelson AS, Phillips PA. Bosentan ameliorates cyclosporin A-induced hypertension in rats and primates. Hypertension 1995; 27: 1341-5.
36. Khanna A, Li B, Sehajpal PK, Sharma VK, Suthanthiran M. Mechanism of action of cyclosporine: a new hypothesis implicating transforming growth factor-β. Transplantation Reviews 1995; 9: 41-8.